Why the study?
Does measurement of high-sensitivity C-reactive protein (HSCRP) improve global risk prediction for future myocardial infarction and stroke in apparently healthy men and women?
Does measurement of high-sensitivity C-reactive protein (HSCRP) improve global risk prediction for future myocardial infarction and stroke in apparently healthy men and women?
HSCRP measurement serves as a strong independent predictor of future cardiovascular events and may improve global risk assessment in primary prevention.
No takes yet. Share an insight, caveat, or question.
Supports hsCRP for refined primary prevention risk models; leaves open whether testing improves outcomes in trials.
Paul M. Ridker (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: